We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.25B
1-Year Est. Return 28.52%
This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+28.52%
3 Year Est. Return
+86.82%
5 Year Est. Return
+110.6%
10 Year Est. Return
+500.3%
AUM
$2.21B
AUM Growth
+$110M
Cap. Flow
-$79.3M
Cap. Flow %
-3.59%
Top 10 Hldgs %
22.7%
Holding
3,121
New
66
Increased
341
Reduced
717
Closed
30

Sector Composition

Rank Sector Weight
1 Technology 17.76%
2 Consumer Discretionary 10.46%
3 Healthcare 9.6%
4 Financials 9.53%
5 Industrials 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BAC icon
51
Bank of America
BAC
$448B
$5.84M 0.26%
242,482
+14,083
+6% +$351K
SPGI icon
52
S&P Global
SPGI
$120B
$5.73M 0.26%
15,905
-1,446
-8% -$510K
HON icon
53
Honeywell
HON
$72.9B
$5.65M 0.26%
36,432
-1,138
-3% -$169K
SBUX icon
54
Starbucks
SBUX
$122B
$5.64M 0.26%
65,676
-1,922
-3% -$153K
LLY icon
55
Eli Lilly
LLY
$1.08T
$5.57M 0.25%
37,647
-1,343
-3% -$208K
SPY icon
56
State Street SPDR S&P 500 ETF Trust
SPY
$807B
$5.26M 0.24%
15,722
-2,243
-12% -$743K
MDY icon
57
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.1B
$5.17M 0.23%
15,260
-18,000
-54% -$6.14M
VCSH icon
58
Vanguard Short-Term Corporate Bond ETF
VCSH
$45B
$5.15M 0.23%
62,170
+16,907
+37% +$1.4M
HD icon
59
Home Depot
HD
$353B
$5.08M 0.23%
18,297
-565
-3% -$153K
XLF icon
60
State Street Financial Select Sector SPDR ETF
XLF
$59B
$4.97M 0.23%
206,540
-41,055
-17% -$998K
EW icon
61
Edwards Lifesciences
EW
$54B
$4.91M 0.22%
61,527
-668
-1% -$52.1K
FDX icon
62
FedEx
FDX
$76.3B
$4.86M 0.22%
19,309
-936
-5% -$187K
VRTX icon
63
Vertex Pharmaceuticals
VRTX
$134B
$4.85M 0.22%
17,830
-411
-2% -$113K
IBM icon
64
IBM
IBM
$225B
$4.77M 0.22%
40,991
-1,767
-4% -$208K
BMY icon
65
Bristol-Myers Squibb
BMY
$130B
$4.76M 0.22%
79,046
-2,440
-3% -$147K
UNP icon
66
Union Pacific
UNP
$174B
$4.64M 0.21%
23,598
-1,229
-5% -$228K
TXN icon
67
Texas Instruments
TXN
$257B
$4.59M 0.21%
32,156
-1,233
-4% -$168K
ILMN icon
68
Illumina
ILMN
$29.1B
$4.58M 0.21%
15,242
-188
-1% -$64.8K
ATVI
69
DELISTED
Activision Blizzard
ATVI
$4.57M 0.21%
56,491
-1,482
-3% -$120K
APD icon
70
Air Products & Chemicals
APD
$68.9B
$4.47M 0.2%
15,013
-997
-6% -$287K
BRO icon
71
Brown & Brown
BRO
$23.9B
$4.42M 0.2%
97,634
-1,565
-2% -$69.8K
CRL icon
72
Charles River Laboratories
CRL
$13.5B
$4.36M 0.2%
19,239
-2,177
-10% -$452K
T icon
73
AT&T
T
$168B
$4.34M 0.2%
201,587
-11,143
-5% -$249K
ADP icon
74
Automatic Data Processing
ADP
$108B
$4.31M 0.2%
30,898
-1,799
-6% -$252K
FDS icon
75
Factset
FDS
$10.1B
$4.28M 0.19%
12,786
-1,575
-11% -$544K

Similar funds

Ameritas Investment Partners's Q3 2020 Portfolio in Review

As of Q3 2020, Ameritas Investment Partners held 3,121 positions worth $2.21B, up 5.2% from $2.1B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ameritas Investment Partners withdrew a net $79.3M in Q3 2020, closing 30 positions and reducing 717 holdings. Its most notable exit was Caesars Entertainment Corporation, an estimated $1.97M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Ameritas Investment Partners opened a new position in Jazz Pharmaceuticals worth $2.24M.

  • Ameritas Investment Partners's largest Q3 2020 buy was Jazz Pharmaceuticals: 15,701 shares worth $2.24M.
  • Ameritas Investment Partners added most to Invesco QQQ Trust in Q3 2020, an estimated $3.73M increase.
  • Ameritas Investment Partners's biggest Q3 2020 reduction was State Street SPDR S&P MIDCAP 400 ETF Trust, cutting an estimated $6.14M.
  • Ameritas Investment Partners fully exited Caesars Entertainment Corporation in Q3 2020, selling an estimated $1.97M.
  • Ameritas Investment Partners's ten largest holdings make up 23% of its $2.21B portfolio in Q3 2020.
  • Ameritas Investment Partners opened 66 new positions and closed 30 in Q3 2020.
  • Ameritas Investment Partners's portfolio value rose 5.2% quarter-over-quarter to $2.21B.

Based on Ameritas Investment Partners's 13F filing for Q3 2020, filed 13 Nov 2020.